The Claim
In obese men with hypogonadism receiving GLP-1/GIP therapy, the combination of resistance training and testosterone replacement results in 16% of total weight loss being lean mass loss, whereas testosterone replacement alone results in 26% of total weight loss being lean mass loss.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In obese men with low testosterone on GLP-1/GIP therapy, adding resistance training to testosterone replacement reduces the amount of muscle lost during weight loss from 26% to 16% compared to testosterone replacement alone.
See the scientific wording
In obese men with hypogonadism on GLP-1/GIP therapy, resistance training combined with testosterone replacement reduces lean mass loss to 16% of total weight loss, compared to 26% with testosterone alone, indicating that resistance training adds significant protective benefit.
Testosterone binds to muscle cells and turns on signals that build muscle, while resistance training pulls on the muscle fibers and turns on the same signals. Together, they strongly activate a key growth switch called mTORC1, which tells the cell to make more muscle proteins and stop breaking them down. This keeps muscle mass from shrinking even when the body is losing weight.
What the research says
1 studyFor obese men with low testosterone on weight-loss drugs, adding weight training to testosterone therapy cuts muscle loss in half — from 26% to 16% of total weight lost — just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.